Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationLiver TransplantationHematopoietic Stem Cell TransplantationTransplantation ConditioningAnemia, AplasticTransplantation ChimeraLeukemiaGraft SurvivalTissue DonorsKidney TransplantationBusulfanBone and BonesHistocompatibility TestingBone Marrow PurgingHistocompatibilityTransplantation, IsogeneicHematopoietic Stem CellsCyclophosphamideBone Marrow DiseasesRecurrenceGraft RejectionHematopoiesisHeart TransplantationCombined Modality TherapyImmunosuppressive AgentsStem Cell TransplantationTreatment OutcomeRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveTransplantation ImmunologyMice, Inbred C57BLLeukemia, Myeloid, AcuteHematologic NeoplasmsLung TransplantationRemission InductionTime FactorsBone Marrow ExaminationHepatic Veno-Occlusive DiseasePrecursor Cell Lymphoblastic Leukemia-LymphomaImmunosuppressionGraft vs Host ReactionLeukemia, MyeloidLymphocyte DepletionAcute DiseaseLeukocyte TransfusionLymphoma, Non-HodgkinBone Marrow NeoplasmsOrgan TransplantationRetrospective StudiesSurvival AnalysisHLA AntigensSevere Combined ImmunodeficiencyT-LymphocytesChimeraCyclosporineColony-Forming Units AssayMyelodysplastic SyndromesActuarial AnalysisHematologic DiseasesLymphocyte TransfusionAntineoplastic Combined Chemotherapy ProtocolsFollow-Up StudiesNuclear FamilySurvival RateCarmustineGraft vs Tumor EffectCell TransplantationPancreas TransplantationCytomegalovirus InfectionsGraft vs Leukemia EffectBone RemodelingPancytopeniaIslets of Langerhans TransplantationCytarabineLeukocyte CountCell DifferentiationDisease-Free SurvivalCord Blood Stem Cell TransplantationMelphalanTransplantationGranulocyte Colony-Stimulating FactorSpleenMice, Inbred BALB CEtoposideLymphomaMultiple MyelomaAntilymphocyte SerumPeripheral Blood Stem Cell TransplantationFlow CytometryTransplantation ToleranceLiving DonorsFatal OutcomePrognosisHodgkin Disease